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INTRODUCTION 
 
In the maintenance of cellular homeostasis the ubiquitin-proteasome system 
(UPS) has pivotal role.  This system is responsible for the rapid and selective 
degradation of short-lived proteins that have mostly regulatory role in the cell. In 
addition, UPS is involved in the quality control of the cellular proteins by 
degrading the irreversible denatured proteins. The first step of this degradation 
system is catalyzed by the ubiquitin ligase enzyme cascade, which recognizes the 
proteins intended for intracellular degradation and marks them by covalently 
attaching a polyubiquitin chain to a lysine residue of the substrate protein. This 
degradation signal is recognized by polyubiquitin receptors, which bind the 
polyubiquitylated proteins and target them for degradation to the 26S proteasome. 
The 26S proteasome, a large multiprotein complex is built up from two 
subcomplexes: the central catalytic core is responsible for the proteolytic 
degradation, while the 19S regulatory complexes recognize the polyubiquitin 
degradation signal, specifically bind these substrate proteins, deubiquitylate and 
unfold the substrate proteins and feed them into the central catalytic particle. 
One of the most controversial fields of proteasome research is the way in 
which polyubiquitin receptors fulfill their job. Although a large amount of 
information was collected by molecular and genetic studies in the yeast 
Saccharomyces cerevisiae, the mechanism how these receptors recognize their 
specific substrates and how they interact with each other and with the 26S 
proteasome is hitherto largely unknown. There are five different polyubiquitin 
receptors in the yeast. Two of them are genuine subunits of the 26S proteasome: 
the Rpn10 contains a single ubiquitin-interaction motif (UIM) involved in substrate 
selection, while in the Rpn13 subunit a pleckstrin-like domain (Pru) is responsible 
for substrate binding. The N-terminal von Willebrand-A domain of Rpn10 and the 
Pru domain of Rpn13 ensure the binding of these subunits to the 26S proteasome. 
The other three polyubiquitin receptors of the yeast (the UBA/UBL proteins 
Rad23, Dsk2 and Ddi1) are extraproteasomal, monomer proteins that bind the 
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polyubiquitylated substrates by their ubiquitin-associated (UBA) domain and 
anchor to the proteasome by their ubiquitin-like (UBL) domain.  
Earlier studies in yeast suggested that polyubiquitylated proteins collected by 
the extraproteasomal ubiquitin receptors are targeted to a large docking surface of 
the proteasome regulatory particle that is formed by the Rpn1/Rpn2 subunits. 
Recent results, however, suggest that in higher eukaryotes the structure and the 
mode of action of polyubiquitin receptors may be different to that observed in 
yeast. Thus, it turned out that the ortholog of Rpn10 in Drosophila, subunit p54, is 
essential, its deletion is lethal in Drosophila, while deletion of Rpn10 in yeast has 
no detectable phenotype. The Drosophila p54 subunit has three UIM motifs and a 
terminal lysine cassette, which is conserved in all higher eukaryotes. Furthermore, 
it was shown that by developmental-specific differential splicing several protein 
products are coded by the ortholog of Rpn10 in mice. In these protein products, 
two UIM motifs appear in different combinations, and the deletion of the embryo 
specific form is lethal. There are two structurally different essential Rpn10 
paralogs in human, one of them, the S5a interacts with the Rad23 extraproteasomal 
polyubiquitin receptor. From these observations it was shown first in higher 
eukaryotes and later also in yeast that the binding of the UBA/UBL polyubiquitin 
receptors to the proteasome is a well orchestrated, controlled process; there are 
well-defined interactions between the polyubiquitin receptors, and each of the 
receptors have their own defined substrates. 
It is know today, that besides a common regulatory protocol the regulation of 
the polyubiquitin receptors may differ substantially in higher eukaryotes, 
depending on the environmental conditions. Contrary to intensive research efforts, 
there is no detailed, uniform model, which describes the mode of action of the 
polyubiquitin receptors. 
AIMS OF THE STUDY 
 
It was known from our previous in vitro studies that in the presence of excess 
zinc ions, the p54 subunit of the Drosophila melanogaster 26S proteasome 
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dissociates from the proteasome, and this process is accompanied by the 
disassembly of the 26S proteasome into its subcomplexes and the loss of the 
catalytic activity. All these changes are fully reversible; removal of the excess zinc 
ions is followed by the reassembly of the 26S proteasome and the regain of the 
catalytic activity. In its dissociated form subunit p54 interacts with several proteins 
involved in protein modification. The reversible dissociation-association of subunit 
p54 is called shuttling. The in vivo relevance of this shuttling was supported by two 
independent observations: 
1. The p54 subunit was present in stochiometric concentration in highly 
purified 26S proteasomes prepared from early embryos, but only in 
substoichiometric concentration in purified 26S proteasomes prepared from 
a mixture of embryos and larvae. This observation suggested that the 
proteasomal concentration of subunit p54 might vary in a developmentally 
regulated pattern. 
2. Our protein cross-linking experiments suggested that in the presence of ATP 
subunit p54 is present in two different conformations in the Regulatory 
Particle. This observation and the interaction of p54 with enzymes involved 
in protein modifications suggested that postsynthetic modification(s) of the 
subunit might promote the shuttling of the subunit and influence its function 
during its extraproteasomal state. 
 
Research plan 
We planned the construction of a transgenic Drosophila system, which would 
allow following the in vivo fate of subunit p54, to prove or reject the idea of in vivo 
shuttling of subunit p54. 
- By the aid of inducible over-expression of Strep-tagged full-length p54 or its 
different domains, we wanted to chase out the endogenous p54 from the 
proteasome, which would allow extending the duration of the extraproteasomal 
state of the subunit to study its postsynthetic modifications or its interactions 
with other cellular proteins. Transgenic full-length p54 or its N-terminal half, 
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which carry the vWA domain required for proteasomal interaction, were planned 
for this purpose. In an alternative approach, we planned to construct a transgenic 
animal expressing the C-terminal half of p54, lacking the vWA domain required 
for proteasomal interaction. Induced over-expression of this transgenic protein 
would model the extraproteasomal state of subunit p54. 
- In an independent set of experiments, we planned to measure the changes in the 
concentration of subunit p54 during the ontogenesis of Drosophila 
melanogaster, and to study the mechanisms, which may regulate its 
concentration. 
- We also planned to analyze the whole spectrum of polyubiquitin receptors 
functioning in Drosophila melanogaster, to map their functional domains and 
their interactions with each other and with the proteasome. 
 
METHODS 
 
In vitro methods: 
- Databases and prediction software applications (NCBI, EBI, FlyBase, IUPred, 
dsCheck) 
- In vitro DNA recombination techniques 
- Nucleic acid preparation from biological sample (genomic DNA, mRNA, cDNA, 
plasmid) 
- Polymerase chain reaction, semiquantitative reverse transcription-coupled PCR 
- Protein preparation from biological samples 
- Protein purification 
Gel-filtration chromatography (FPLC) 
  Affinity chromatographic methods 
  Ion-exchange chromatography (FPLC) 
  Hydrophobic-interaction chromatography (FPLC) 
- Separation of proteins by gel electrophoresis  (Native-PAGE,  denaturing (SDS)-
PAGE and 2D-IEF-SDS PAGE) 
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- Protein identification and visualization: 
  Antibody production and immunoblotting techniques 
  Protein staining by different methods 
-  Detection of protein-protein interactions and protein modifications: 
  Immunoprecipitation 
  Chemical cross-linking 
  Pull-down experiments with recombinant and endogenous proteins 
  Preparation of samples for mass-spectrometric identification 
 
In vivo methods: 
- Establishment of transgenic Drosophila stocks by P-element transformation  : 
Induced transgenic protein production in flies 
Induced gene silencing (RNAi) 
- Synchronizing the egg laying of flies 
- Analysis of genetic interactions 
 
RESULTS 
 
1) Drosophila melanogaster has three polyubiquitin receptors. 
Based on sequence- and structural homologies we found that the yeast 
polyubiquitin receptor orthologs (p54 and Rpn13, Rad23, Dsk2 and Ddi1) are 
present in Drosophila melanogaster, as well. We made cDNA libraries from 
embryonic and larval total RNA and successfully amplified the cDNAs of the 
supposed polyubiquitin receptors using specific oligonucleotide primers in PCR 
reaction. We mapped the functional domains of the GST-tagged recombinant 
proteins in pull-down experiment and demonstrated that only three out of the five 
receptors (p54, Rad23 and Dsk2) are active in Drosophila. Among them, the 
proteasome subunit p54 carries three ubiquitin-interacting motifs (UIMs) 
responsible for the binding of polyubiquitilated proteins, while the Dsk2 and 
Rad23 carries the ubiquitin-associated domain (UBA) that specifically binds the 
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substrates. Although we proved that the Drosophila Ddi1 and Rpn13 have similar 
domain structure as it was found in the yeast orthologs, they were unable to bind 
polyubiquitilated substrates in fruit fly. Using different transgenic stocks (RNA-
interference constructs to knock down and protein over-expressing constructs) in in 
vivo studies, we confirmed our in vitro result that the p54, Rad23 and Dsk2 are the 
main polyubiquitin receptors in Drosophila.  
 
2) The concentration of the Drosophila polyubiquitin receptors changes in a 
developmentally regulated fashion. 
Total protein extracts were prepared from animals in different developmental 
stages, and the subunit compositions (including the p54) of the 26S proteasome 
were analyzed by immunoblotting technique. We found that the concentration of 
the p54 polyubiquitin receptor subunit, relative to those of other proteasome 
subunits falls suddenly at the end of embryogenesis, remains low throughout the 
larval stages, starts to increase again in the late third instar larvae and remains high 
in the pupae, adults and embryos. A similar developmentally regulated fluctuation 
was observed in the concentrations of the Rad23 and Dsk2 extraproteasomal 
polyubiquitin receptors. Surprisingly, in contrast to the serious reduction in the 
concentrations of the polyubiquitin receptors, there was no detectable accumulation 
of the polyubiquitylated proteins during the early larval stages. We suppose that 
during the larval stages the catalytic activity of the proteasome is muted, although, 
we have only speculations on the biological relevance of this phenomenon. 
 
3) Polyubiquitin receptors are selectively degraded during the larval stages. 
We demonstrated that the level of the mRNAs encoding the p54, Rad23 and 
Dsk2 polyubiquitin receptors remained constant during the ontogenesis of 
Drosophila. It suggested that their depletion in the early larval stages is not 
transcriptionally regulated. We found that the polyubiquitin receptors are 
proteolytically degraded by a specific protease. We purified the enzyme till 
homogeneity and identified it as a serine-protease by mass spectrometry. Although 
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the in vitro and in vivo examination of the serine-protease is still in progress, we 
proved that the enzyme is essential, it is active throughout the larval stages, and it 
is inhibited (transcriptionally and by a selective inhibitor) at the end of the larval 
cycle.  
Although we don’t know the relevance of this regulation, we suppose that the 
irreversibly misfolded proteins that are proteasome substrates in non-larval stages, 
are degraded by larvae-specific serine-proteases in larval stages. Thus, the activity 
of the proteasome has to be limited in larvae. The elimination of the polyubiquitin 
receptors by a serine-protease is the simplest and most economical way of 
proteasome inactivation. 
 
4) Only the C-terminal half of p54 is degraded during the larval stages. 
We found that during the degradation of p54 the N-terminal domain of the 
protein remains intact. We predicted and experimentally confirmed that the C-
terminal part of p54 is intrinsically unstructured. It turned out that the serine-
protease identified as polyubiquitin receptor-hydrolyzing enzyme selectively 
degrades the unstructured region within p54. Because Rad23 and Dsk2 also contain 
extended unstructured regions, we suppose that the selectivity of the serine-
protease is related to this structural feature of the polyubiquitin receptors. 
 
5) Transgenic p54 and its N-terminal half incorporated into the proteasome. 
To follow the in vivo fate of subunit p54, transgenic lines encoding the Strep-
tagged N-terminal half (NTH) or full-length p54 subunits have been established in 
the inducible Gal4-UAS system. We demonstrated that the whole-body expression 
of the full-length subunit or its NTH did not produce any detectable phenotypic 
changes and these vWA domain bearing transgenic products were quantitatively 
incorporated into the 26S proteasome. Our original goal to chase out the 
endogenous p54 failed due to the low expression level of transgenic proteins. 
According to our indirect results we suppose that the coordinated regulation of the 
genes encoding proteasomal subunits limited the over-expression of the transgenes. 
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6) The C-terminal half of p54 is accumulated extraproteasomally, it is 
ubiquitylated in its terminal lysine residues and caused third instar larval 
lethality. 
To mimic the extraproteasomal state of p54, transgenic stocks encoding the C-
terminal half of p54 (p54-CTH) has been established. As expected, gel-filtration 
chromatography revealed that the ectopically over-expressed transgenic p54-CTH 
lacking the vWA domain was not incorporated into the 26S proteasome, 
accumulated extraproteasomally and caused third instar larval lethality. We affinity 
purified the Srep-tagged version of p54-CTH and its covalently modified 
derivatives from larvae, further fractionated them on 2D-IEF-SDS-PAGE and 
analyzed by mass spectrometry. We proved that the p54-CTH is 
extraproteasomally ubiquitylated. Our in vivo studies revealed that the p54-CTH is 
ubiquitylated in its terminally localized conserved (in higher eukaryotes) lysines, 
and this ubiquitylation is definitely not a degradation signal to the proteasome. We 
suppose that the C-terminal conserved lysines of p54 are mono-and/or 
multiubiquitylated, and this postsynthetic modification is responsible for the 
shuttling and structural integrity of the protein. 
 
7) The serine-protease mediated developmental-stage-specific regulation of 
polyubiquitin receptors is inhibited by the p54-CTH. 
We found that the polyubiquitin receptors accumulate in earlier larval stages in 
p54-CTH over-expressing transgenic animals than in wild-type controls. We 
proved that the extraproteasomally accumulated and multiubiquitylated transgenic 
p54-CTH transcriptionally limited the larval expression of the selective serine-
protease responsible for degradation of polyubiquitin receptors. This observation 
suggests that the serine-protease and the post synthetically modified p54-CTH 
mutually regulate each other in order to fine-tune the ubiquitin-proteasome system 
during the ontogenesis. 
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8) p54-CTH inhibits the proteasomal degradation of polyubiquitylated 
protein.  
Surprisingly, contrary to the premature accumulation of the polyubiquitin 
receptors following the over-expression of p54-CTH, there was a significant 
accumulation of polyubiquitylated proteins in early larval stages. How can we 
interpret this observation? We found that the extraproteasomally-localized p54-
CTH, which carries three UIMs, efficiently binds not only the p54-specific 
polyubiquitylated proteins, but also the Dsk2 extraproteasomal polyubiquitin 
receptor. In this way, the p54-specific substrates and the Dsk2 are entrapped, due 
to the lack of the vWA domain of p54-CTH. Thus, their transport to the 
proteasome is completely hindered, resulting in the accumulation of the 
polyubiquitylated proteins. The disturbance in the balance of polyubiquitylated 
substrate degradation causes the death of p54-CTH over-expressing transgenic 
animals.  
 
9) The Drosophila Dsk2 binds to the proteasome through the p54 subunit. 
Our in vitro pull-down experiments revealed that the Dsk2 UBL efficiently 
binds to the third UIM of p54 polyubiquitin receptor. Furthermore we proved that 
proteasomes lacking the p54 subunit (prepared from p54-null- or p54-silenced 
Drosophila mutants) were unable to bind to the Dsk2 protein, although, the binding 
was efficient in the case of p54-containing wild-type proteasomes. Using 
polyubiquitin receptor over-expressing and/or silencing transgenic lines, we found 
strong genetic interaction between p54 and Dsk2. According to our in vitro and in 
vivo results, contrary to the yeast model in which Dsk2 binds to the proteasome via 
the Rpn1/Rpn2 surface, the Drosophila Dsk2 interacts with the proteasome 
through the p54 shuttling factor.  
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CONCLUSIONS 
 
The cellular concentration of the three main polyubiquitin receptors of 
Drosophila melanogaster (the proteasomal subunit p54 and the extraproteasomal 
Dsk2 and Rad23 proteins) is developmentally regulated. The concentration of the 
receptors is very high during the embryonic-, pupal- and adult stages, ensuring 
high activity of the ubiquitin-proteasome system. We suppose that during these 
developmental stages a specific ubiquitin-ligase multiubiquitylates the terminal 
lysines of subunit p54, which induces a conformational change in the subunit 
required for its dissociation from the proteasome. In addition, the 
multiubiquitylation may stabilize the subunit during its dissociated state, protecting 
it against the proteolytic action of cytosolic proteases. As the dissociation-
association equilibrium of subunit p54 is shifted towards the reassociation, the 
duration of the extraproteasomal state of the subunit is very short. In the 
dissociated state of subunit p54 its UIM1 and UIM2 motifs recruit and bind a 
specific set of polyubiquitylated proteins, which are processed for proteolysis 
exclusively by this polyubiquitin receptor. The third UIM motif of p54 recruits and 
binds the UBL domain of Dsk2 charged with its own polyubiquitylated substrates. 
In its uncharged state the UBL domain of Dsk2 is masked by an intramolecular 
interaction with the UBA domain of the same Dsk2 receptor molecule, preventing 
its interaction with subunit p54. As the UBA domain of Dsk2 has much higher 
affinity for polyubiquitylated proteins than the for its own UBL domain, in the 
presence of a suitable polyubiquitylated protein (belonging to the group of specific 
substrates processed by Dsk2) the UBL domain is unmasked, ensuring its 
association with the UIM3 motif of p54. This mechanism ensures that p54 will 
recruit and bind only substrate-charged Dsk2 receptors. Following the 
deubiquitylation of p54, the subunit will reassociate with the proteasome. The 
reassociation, which is supported by chaperon proteins, presents the 
polyubiquitylated proteins for proteasomal degradation. The shuttling of p54 will 
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coordinately present two different sets of polyubiquitylated proteins for 
degradation.  
During the larval stages, due to the almost complete cessation of mitotic 
activity, the generation of polyubiquitylated proteins drops to a low level, that is 
accompanied by a decline of proteasomal activity. This decline is ensured by a 
proteolytic degradation of the polyubiquitin receptors. During the larval stages an 
essential serine-protease emerges, which can selectively recognize and degrade the 
unstructured regions of free- and proteasome-bound polyubiquitin receptors, 
leading to the inactivation of the ubiquitin-proteasome system. We suppose that 
during the larval stages, due to the hypoxic life conditions, a large amount of 
irreversibly denatured protein is produced, which are removed by a specific serine-
protease capable of more efficiently degrading these damaged proteins than the 
proteasome. At the end of the larval developmental phase, this selective proteolytic 
activity is abolished by the appearance of specific inhibitor. This results in the 
accumulation of polyubiquitin receptors, as the concentration of the polyubiquitin 
receptor-specific mRNAs is constant during the development. The accumulated 
p54 in its multiubiquitylated form inhibits the transcription of the gene encoding 
this specific serine-protease, accelerating the reactivation of the ubiquitin-
proteasome system. 
The biological relevance of this developmental regulation is not known in 
all details. We have to emphasize that the very high mitotic activity during the 
embryonic stage, the histolysis of the larval structures during the pupal stages as 
well as the high reproductive activity during the adult stage requires high activity 
of the ubiquitin-proteasome system, which is ensured by high polyubiquitin-
receptor concentration. 
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